PSU Congenital and Structural Heart Disease: One world One heart; Unite for Mankind
- Prince of Songkla University
King chulalongkorn memorial hospital, Chulalongkorn University, Thailand
| ● RVOT morphology and suitability | Ankavipar Saprungruang |
| ● Valve selection | Gejun Zhang |
| ● Tips and tricks to facilitate the implantation | Gareth Morgan |
| ● Overcoming the possible complications | Sir Shakeel Qureshi |
| ● Three cases I'll never forget | Horst Sievert |
| ● How to reduce the human errors and optimize the procedure results |
Mario Carminati |
| ● How to be a good and a great interventionist | Sir Shakeel Qureshi |
| ● Neurologist Perspective | Sureerat Suwatcharangkoon |
| ● Cardiologist Perspective | Mann Chandavimol |
| ● Optimize timing for PV replacement | Saviga Sethasathien |
| ● How I can make your PPVI easier with imaging | Phuoc Duong |
| ● Paradigm shift in TOF repair | Pirapat Makarapong |
| ● Hybrid PPVI: benefits and risks | Robin Hay-son Chen |
| ● Introduction to VenusA-Pro System: Design and Clinical outcomes |
Jianfang Luo |
| ● Procedural Optimization to Minimize Conduction Disturbances |
Tasalak Thonghong |
| ● TAVI Durability: What We Know, What We Don't and When Will We Know |
Kid Bhumimuang |
| ● TAVI for Bicuspid AS: Optimal Sizing, Positioning & Valve selection |
Yuan Feng |
| ● PSU in collaboration with China | Roengsak Leetanaporn |
| ● China Structural Revolution | Hou-Sen Lim |
| ● Biodegradable device, where are we now | Shouzheng Wang |
| ● Special considerations in ASD closure | |
| In small children | Jonas Del Rosario |
| In deficient rims | Hideshi Tomita |
| In the elderly | Thanawat Suesat |
| ● Which ASDs I won't urge interventionist to close? | Tawai Ngernsritrakul |
| ● Echo and Cath Gradients Discordant post TAVR: what we have learned and how to apply |
Amr E Abbas |
| ● Sapien 3 and small annuli: Technical Issue and Clinical Outcomes |
Nattawut Wongpraparut |
| ● Updated in S3 Optimal sizing, Positioning and Possible Repeating |
Narathip Chunhamaneewat |
| ● Debate Topic: When our patients need TAVI valve for the first time in 2023 |
|
| Self–Expandable TAVR is the way to go! | Tasalak Thonghong |
| Balloon–Expandable Valve is better! | Nattawut Wongpraparut |
| ● Advancements in Evolut platform and durability | Jeffrey Popma |
| ● Patient screening and selection for TEER; What to consider in 2023 |
Tawai Ngernsritrakul |
| ● Live in a box: Mitra Clip | Krissada Meemook |
| ● DragonFly | Yuan Feng |
| ● Case base learning and round table discussion (30 min) | Kanyalak Vithessonthi |
| ● When do the patients need AICD, not PPVI? | Supaluck Kanjanauthai |
| ● Pre-assessment of patients with RVOT dysfunction-what is the optimal strategy |
Dan Levi |
| ● VSD anatomy and 3D imaging | Ankavipar Saprungruang |
| ● Which device for which morphology? | Do Nguyen Tin |
| ● Tips & Tricks for non fluoroscopic septal closure from Indonesia |
Radityo Prakoso |
| ● How we set up cardiac intervention in Nepal | Manish Shrestha |
| ● Work-Life-Flow: How you can follow my path to celebrate next year together |
Sir Shakeel Qureshi |
Welcome to ‘PSU CSHD: One world One heart; Unite for Mankind’ the meeting which will be held at Naradhiwas Rajanagarindra Heart Center (NRHC), Prince of Songkla University (PSU) in Southern Thailand. This is our first collaborative meeting with the Congenital and Structural Intervention (CSI) Foundation and Queen Sirikit National Institute of Child Health (QSNICH) to celebrate NRHC’s 20th anniversary.
Naradhiwas Rajanagarindra Heart Center, the University Cardiac center in Southern Thailand, was established in 2002 to provide high-quality comprehensive care for patients with congenital and structural heart diseases (CSHD). We have continued developing since that opening, and currently, we are one of the most advanced cardiac centers in Thailand and the Asia Pacific. We are now expanding our therapeutic modalities to heart disease treatment including cardiac surgery, congenital/structural/coronary artery catheter interventions, electrophysiology studies, and catheter ablation. Throughout our two decades, we have continually strived for excellence as we recognize that medical technologies move quickly, and knowledge is endless to learn. As we have been learning tremendously from all the living legends around the globe, we respect that sharing knowledge and experience is a powerful vehicle for learning in the disruptive world. It remains our goal to continue to be an ever-improving regional and international training hub for inspiring young generations to learn and commit to patient-center care as the heart of our practice.
To commemorate NRHC’s 20th anniversary, we would like to invite you to take this opportunity to network with mentors, mentees, and friends to learn, unlearn, and relearn together. Please join us on April 5-6 with 10 live cases and keynote lectures from regional and international key opinion leaders in the field of transcatheter valve replacement, device closure for septal defects, and how to be a good and great interventionist as our respectful legends. You can also have an opportunity to see the latest device technologies from a variety of industry exhibitions. Last but not least, ‘Lipe’ one of our most beautiful islands is waiting for you and your family to get full energy recharged after the meeting.
We promise you a warm welcome with a wonderful meeting atmosphere at PSU NRHC to Push the boundaries of Surgical and Interventional UNRivalled Heart Care.
Please JOIN US! https://nrhc.medicine.psu.ac.th
Sincerely,
PSU CSHD TEAM
This will close in 20 seconds